Pfizer Inc.
Diagnostic anti-PD-L1 antibody and use thereof

Last updated:

Abstract:

The present invention provides for an antibody or antigen-binding fragment thereof which binds to an epitope within human PD-L1 with high specificity and reproducibility. The inventive antibody or antigen-binding fragment thereof may be used in assessing PD-L1 expression in tissue samples to aid in patient stratification. The present invention further provides methods of producing the inventive antibody.

Status:
Grant
Type:

Utility

Filling date:

20 Sep 2017

Issue date:

11 Aug 2020